BioGX Receives CE Mark For Influenza, RSV Assay

News   Oct 07, 2016

 
BioGX Receives CE Mark For Influenza, RSV Assay
 
 
 

RELATED ARTICLES

Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease Diagnosis

News

The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.

READ MORE

RNA That Helps Grow Blood Vessels Could Aid Heart Disease Research

News

STEEL, a noncoding RNA, acts on genes to stimulate produce of blood vessels, a finding which could advance efforts to combat heart disease.

READ MORE

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

News

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE